In vivo search for butyrate responsive sequences using transgenic mice carrying (A)γ gene promoter mutants

Blood

Volumn 88, Issue 3, 1996, Pages 1079-1083

  Pace, Betty S ^a   Li, Qiliang ^b   Stamatoyannopoulos, George ^b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOBUTYRIC ACID; BUTYRIC ACID; GAMMA GLOBIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLOBIN GENE; GLOBIN SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RETICULOCYTE; TRANSGENIC MOUSE;

EID: 0029768863     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.1079.bloodjournal8831079     Document Type: Article

References (23)

1. Ginder GD, Whitters MJ, Pohlman JK: Activation of a chicken embryonic gene in adult erythroid cells by 5-azacytidine and sodium butyrate. Proc Natl Acad Sci USA 81:3954, 1984
2. Perrine SP, Rudolph A, Faller DV: Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci USA 85:8540, 1988
3. Constantoulakis P, Papayannopoulou T, Stamatoyannopoulos G: α-Amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood 72:1961, 1988
4. Constantoulakis P, Knitter G, Stamatoyannopoulos G: On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatment with 5-AzaC and AraC. Blood 74:1963, 1989
5. A γ transgenic mice: A new model for studying the induction of fetal hemoglobin in the adult. Blood 77:1326, 1991
6. Perrine SP, Ginder GD, Faller DV, Dover GJ, Ikuta T, Witkowska HE, Cai S, Vichinsky EP, Olivieri NF: A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N Engl J Med 328:81, 1993
7. Dover GJ, Brusilow S, Samid D: Increased fetal hemoglobin in patients receiving sodium 4-phenylbutryate. N Engl J Med 327:569, 1992
8. Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivier NF: Extended therapy with intravenous arginine butyrate in patients with β hemoglobinopathies. N Engl J Med 332:1606, 1995
9. Perrine S, Pekatos P, Faller DV, Bergsagel J, Ikuta T, Dover G, Phipps K, Fournarakis B, Boosalis V, Stamatoyannopoulous G, Brauer M, Huerta P, Cao M, Travis M, Atweh GF: Hematological efficacy and elimination of transfusion requirements in thalassemia major by intermittent low-dose butyrate therapy. Blood 86:482, 1995 (abstr)
10. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture, Mol Cell Biochem 42:65, 1982
11. Glauber JG, Wandersee NJ, Little JA, Ginder GD: 5′-Flanking sequences mediate butyrate Stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol 11:4690, 1991
12. Bohan C, York D, Srinivasan A: Sodium butyrate activates human immunodeficiency virus long terminal repeat - directed expression. Biochem Biophys Res Commun 148:899, 1987
13. Fregeau CJ, Helgason CD, Bleackley RC: Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate. Nucleic Acids Res 20:3113, 1992
14. 3-and butyrate-inducible responses. Proc Natl Acad Sci USA 90:2984, 1993
15. Knochbin S, Wolffe AP: Developmental regulation and butyrate-inducible transcription of the Xenopus histone H1 promoter. Gene 128:173, 1993
16. Pace B, Li Q, Peterson K, Stamatoyannopoulos G: α-Amino butyric acid fails to reactivate the totally silenced γ gene of the β locus YAC. Blood 84:4344, 1994
17. Stamatoyannopoulos G, Josephson B, Zhang J, Li Q: Developmental regulation of human y globin genes in transgenic mice. Mol Cell Biol 13:7636, 1993
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
19. Current Protocols in Molecular Biology. New York, NY, Wiley, 1991
20. A-γ-globin gene in Greek hereditary persistence of fetal haemoglobin. Nature 313:323, 1985
21. Collins FS, Metherall JE, Yamakawa M, Pan J, Weissman SM, Forget BG: A point mutation in the Ag-globin gene promoter in Greek hereditary persistence of fetal haemoglobin. Nature 313:325, 1985
22. Jane SM, Ney PA, Vanin EF, Gumucio DL, Nienhuis AW: Identification of a stage selector element in the human γ-globin gene promoter that fosters preferential interaction with the 5′ HS2 enhancer when in competition with the β-promoter. EMBO J 11:2961, 1992
23. Pace B, Elford H, Stamatoyannopoulos G: Transgenic mouse model of pharmacologic induction of fetal hemoglobin: Studies using a new ribonucleotide reductase inhibitor, Didox. Am J Hematol 45:136, 1994